Top Story

Everybody Else Is Reading This

Maria Butina Plea Reminds Us How Easy It Is To Turn Thirsty Men Above The Law Behind The Supreme Court’s Dodge: Three Justices Rebuke Kavanaugh And Roberts For Ducking A Big Case How Appealing Ex-Lehman President Commemorates Tenth Anniversary Of Collapse By Shuttering His Hedge Fund Dealbreaker Saudi Arabia’s ‘Black Swan’ Policymaking Breaking Energy

By MedCity News on December 14, 2018

Maria Butina Plea Reminds Us How Easy It Is To Turn Thirsty Men Above The Law

Behind The Supreme Court’s Dodge: Three Justices Rebuke Kavanaugh And Roberts For Ducking A Big Case How Appealing

Ex-Lehman President Commemorates Tenth Anniversary Of Collapse By Shuttering His Hedge Fund Dealbreaker

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.

Saudi Arabia’s ‘Black Swan’ Policymaking Breaking Energy

Partnership Post

When Investment Rhymes with Canada

Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.

By Julien Rosan and Tina Kotrych - Global Affairs Canada

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab